Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elastin Peptides as a Marker of Frailty in Elderly Cancer Patients
NCT02807129Completed
- Sponsor
- CHU de Reims
- Start
- Jan 2014
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU de Reims. Primary endpoint: Elastin peptides quantification at 36 months. Started Jan 2014; status: completed.
Beyond the preview
Go deeper on NCT02807129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807129.